Sort
30,917 grants matching “tumor microenvironment”
In Vivo Oncogene-Induced Tumorigenesis and Escape
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2017 · CA
In Vivo Oncogene-Induced Tumorigenesis and Escape
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2021 · CA
Cell Cycle Checkpoint that Monitors Morphogenesis
$382,239Daniel J Lew · Duke University · R01 · FY2011 · GM
Cell Cycle Checkpoint that Monitors Morphogenesis
$382,239Daniel J Lew · Duke University · R01 · FY2012 · GM
Targeting of STAT3 Signaling Enhances Efficacy of Breast Cancer Immunotherapy
$382,222Ralph A. Reisfeld · Scripps Research Institute, The · R01 · FY2011 · CA
Specialized Niches for Pediatric Astrocytoma Cells
$382,206Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2014 · CA
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2021 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2019 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2020 · HL
MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity
$382,183Sudarshan Anand · Oregon Health & Science University · R01 · FY2018 · HL
Optimizing Targeted Breast Cancer Therapy by Mathematical Modeling and Experimental Studies
$382,141William Thomas Baumann · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · CA
Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome
$382,051Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2020 · CA
Leaders of Scientific Research Programs
$382,029Peter A Jones · University Of Southern California · P30 · FY2013 · CA
Migration Networks
$382,025Frank B Gertler · Massachusetts Institute Of Technology · U54 · FY2011 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$382,013Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$382,013Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Therapeutic Mechanism of CD47 Blockade in Suppressing Melanoma Metastasis
$382,012Alexander D Boiko · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Mechanisms of Carcinogenesis in Biliary Epithelia
$381,978Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2016 · DK
Innate Immune Therapy for B-Cell Malignancies
$381,967John C Byrd · Ohio State University · P01 · FY2015 · CA
Innate Immune Therapy for B-Cell Malignancies
$381,967John C Byrd · Ohio State University · P01 · FY2016 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$381,961Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2024 · NS
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$381,907Jenny J Yang · Georgia State University · R33 · FY2020 · CA
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$381,856Lieping Chen · Yale University · P50 · FY2020 · CA
Pyk2 regulates extracellular vesicles release in GBM cells and modulates activation of tumor infiltrating myeloid cells
$381,843Lilia Kucheryavykh · Universidad Central Del Caribe · R15 · FY2024 · CA